[Retracted] The Disparity in the Management of Polycystic Ovary Syndrome between Obstetrician-Gynecologists in Different-Level Hospitals under the Hierarchical Medical System
Table 1
General information provided by the study participants.
Overall ()
Primary hospital ()
Secondary hospital ()
Tertiary hospital ()
value
Sex
Female
2256 (98.2)
300 (99.7)
1192 (99.0)
764 (96.3)
<0.001
Male
42 (1.8)
1 (0.3)
12 (1.0)
29 (3.7)
<0.001
Age
18-35
335 (14.6)
28 (9.3)
120 (10.0)
187 (23.6)
<0.001
36-45
890 (38.7)
124 (41.2)
466 (38.7)
300 (37.8)
NS
>45
1073 (46.7)
149 (49.5)
618 (51.3)
306 (38.6)
<0.001
Specialty
Ob-Gyn
2117 (92.1)
296 (98.3)
1151 (95.6)
670 (84.5)
<0.001
Repro-Endo
181 (7.9)
5 (1.7)
53 (4.4)
123 (15.5)
<0.001
No. of patients with PCOS treated annually
<50
1649 (71.8)
269 (89.4)
915 (76.0)
465 (58.6)
<0.001
50-200
511 (22.2)
24 (8.0)
247 (20.5)
240 (30.3)
<0.001
>200
138 (6.0)
8 (2.6)
42 (3.5)
88 (11.1)
<0.001
The chief complaint about clinic attendance in patients with PCOS
Menstrual disorders
1833 (78.9)
223 (74.1)
957 (79.5)
653 (82.3)
0.009
Infertility
405 (17.6)
67 (22.2)
217 (18.0)
121 (15.4)
<0.001
Obesity/IR
39 (1.7)
5 (1.7)
17 (1.4)
17 (2.1)
0.017
Hirsutism/acne
14 (0.6)
5 (1.7)
8 (0.7)
1 (0.1)
0.013
Others
7 (0.3)
1 (0.3)
5 (0.4)
1 (0.1)
NS
Estimated national prevalence of IR in patients with PCOS (%)
0-30
1398 (80.8)
211 (70.1)
766 (63.8)
419 (52.8)
<0.001
31-60
754 (32.8)
72 (23.9)
382 (31.8)
300 (37.8)
<0.001
>60
146 (6.4)
18 (6.0)
54 (4.4)
74 (9.4)
<0.001
Estimated national prevalence of obesity in patients with PCOS (%)
0-30
748 (32.6)
142 (47.2)
387 (32.1)
219 (27.6)
<0.001
30-50
909 (39.5)
87 (26.9)
495 (41.1)
327 (41.2)
<0.001
50-80
522 (22.7)
51 (16.9)
254 (21.2)
217 (27.4)
<0.001
>80
119 (5.2)
21 (7.0)
68 (5.6)
30 (3.8)
NS
Ob-Gyn = obstetrician-gynecologists (specialization outside of reproductive medicine); Repro-Endo = reproductive endocrinologists; PCOS = polycystic ovary syndrome; IR = insulin resistance; NS = not significant.
